Ranking · Unmet Need
Research Gap Index
Burden percentile minus research-activity percentile (publications, last 5 years) within the same scope. Positive values flag cancers with high mortality burden but comparatively little literature. Caveat (Phase 1): literature counts are query-based per entity (query stored on each row); they are not aggregated over descendants.
Computedci-research-gap-v1unit: percentile pointshigher = worseAll metrics
| Rank | Δ | Cancer | Research Gap Index (percentile points) | Percentile | Confidence | Sources | Why #n? |
|---|---|---|---|---|---|---|---|
| 1 | = | Malignant Central Nervous System Neoplasm | +60 | 100 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598065 |
| 2 | = | Malignant Uterine Corpus Neoplasm | +36.7 | 96.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598066 |
| 3 | = | Malignant Colon Neoplasm | +23.4 | 93.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598067 |
| 4 | = | Malignant Kidney Neoplasm | +16.7 | 90 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598068 |
| 5 | = | Malignant Esophageal Neoplasm | +13.4 | 86.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598069 |
| 5 | = | Non-Hodgkin Lymphoma | +13.4 | 86.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598070 |
| 7 | = | Malignant Liver Neoplasm | +13.3 | 80 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598072 |
| 7 | = | Malignant Pancreatic Neoplasm | +13.3 | 80 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598071 |
| 9 | = | Malignant Salivary Gland Neoplasm | +10 | 73.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598073 |
| 10 | = | Malignant Laryngeal Neoplasm | +6.7 | 70 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598074 |
| 11 | = | Malignant Vulvar Neoplasm | +6.6 | 66.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598075 |
| 12 | = | Malignant Vaginal Neoplasm | +3.3 | 63.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598076 |
| 13 | = | Malignant Bladder Neoplasm | +3.3 | 60 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598079 |
| 13 | = | Malignant Lung Neoplasm | +3.3 | 60 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598077 |
| 13 | = | Multiple Myeloma | +3.3 | 60 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598078 |
| 16 | = | Cutaneous Melanoma | 0 | 50 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598080 |
| 17 | = | Leukemia | -3.4 | 46.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598081 |
| 17 | = | Malignant Mesothelioma | -3.4 | 46.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598082 |
| 19 | = | Malignant Prostate Neoplasm | -6.6 | 40 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598083 |
| 20 | = | Malignant Nasopharyngeal Neoplasm | -6.7 | 36.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598084 |
| 21 | = | Malignant Breast Neoplasm | -6.7 | 33.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598085 |
| 21 | = | Malignant Rectal Neoplasm | -6.7 | 33.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598086 |
| 23 | = | Malignant Anal Neoplasm | -10 | 26.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598089 |
| 23 | = | Malignant Hypopharyngeal Neoplasm | -10 | 26.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598088 |
| 23 | = | Malignant Ovarian Neoplasm | -10 | 26.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598087 |
| 26 | = | Hodgkin Lymphoma | -13.3 | 16.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598090 |
| 27 | = | Malignant Penile Neoplasm | -23.3 | 13.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598091 |
| 27 | = | Malignant Testicular Neoplasm | -23.3 | 13.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598092 |
| 29 | = | Malignant Thyroid Gland Neoplasm | -30 | 6.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598093 |
| 30 | = | Malignant Gastric Neoplasm | -33.3 | 3.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598094 |
| 31 | = | Malignant Cervical Neoplasm | -40 | 0 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2598095 |
Data updated 16 hours agoSource updated unknown31 eligible entities · inputs hash 088311e223cfb58f2ea8ae32